scholarly journals Role of Agnikarma in Pain Management of Various Musculoskeletal Disorders: A Review Study

Author(s):  
Badwe Yogesh ◽  
Shilvant Rishabh ◽  
Shinde Jyoti

Agnikarma is one of the important Para-surgical procedures described in Ayurveda, which has been widely used in the clinical practice now days. Sushruta has given detail description about Agnikarma. Superiority of Agnikarma over other the treatment modalities are timely described by our ancienter because of its Apunrabhavatva i.e., no recurrence property. Pain (Ruja) is the cardinal feature of most of the musculoskeletal disorders and it can affect the quality of life. In modern lifestyle, patient needs instant relief from pain. Treatment available in modern medicine commonly NSAID’s (Nonsteroidal anti-inflammatory drugs) but it has some hazardous effects on body. This review is an attempt has been made to study various research article, analyzed the role of Agnikarma and its applicability on various painful disorders which help to gain best knowledge about Agnikarma. In this article total 15 research works from various journals have been studied conducted on Agnikarma. Agnikarma was found very important tool in pain management of many musculoskeletal disorders. It was found safe, easy, cost-effective and OPD level procedure.  

2021 ◽  
Vol 12 (5) ◽  
pp. 60-62
Author(s):  
Swati Bhandari ◽  
Divya Badwal ◽  
Ruby Rani Agarwal

Dysmenorrhea is a medical condition characterized by severe uterine pain during menstruation. It is one of the most common gynaecological complaints observed. It has a high impact on women’s quality of life resulting in a restriction of daily activities, a lower academic performance, and poor quality of sleep and has negative effects on mood, causing anxiety and depression. Dysmenorrhea is explained as an Udavartini Yonivyapad in Ayurveda. The main clinical feature of Udavartini is rajahkricchrata i.e., painful menstruation. Today’s stressful modern lifestyle and faulty food habits i.e., increased consumption of oily and junk food is leading to a higher incidence of dysmenorrhea. In modern medicine, dysmenorrhea is treated by oral hormonal pills, non-steroidal anti-inflammatory drugs, and analgesics. Long term use of these produces side effects. Thus, these are not the solution to the problem. The role of diet has been well considered as an etiological factor responsible for causing dysmenorrhea. Ayurveda has given importance to diet and regimen as a part of Chikitsa. Thus, taking an appropriate diet (Pathya Ahara) and avoiding a faulty diet (Apathya Ahara) will help in prevention as well as reducing the symptoms of dysmenorrhea.


2020 ◽  
Author(s):  
Ahmed Mostafa Kotb Aziz

Osteoarthritis (OA) is a chronic degenerative joint disease of dynamic pathology with multiple etiologies. It involves progressive process of softening, loss of articular cartilage, subchondral bone sclerosis, development of osteophytes, and cyst formation. OA usually contributes to decreased activity associated with aging, secondary to diminished function and pain, thus consequently impairing quality of life. It is well established that pain due to OA, swelling, or stiffness can make it difficult for individuals to perform simple daily living activities. Although OA is not curable, a variety of treatment modalities are available to improve symptoms. Main elements include pain management maneuvers, education, changing lifestyle physical activity (PA), and weight reduction in case of overweight. Although total joint arthroplasty (TJA) is considered a cost-effective treatment for people with OA, TJA should only be considered after failure of conservative treatments. Symptoms of OA are usually managed by either pharmachological or nonpharmachological protocols; joint replacement surgeries are considered in advanced cases. Analgesics remain the keystone of pharmacological treatment for OA symptoms, including paracetamol, topical and oral nonsteroidal anti-inflammatory drugs (NSAIDs), and opioids. However, benefits from paracetamol and opioids are minimal, and NSAIDs are not ideal for many patients because they have many side-effects. Intra-articular therapies such as corticosteroids are also commonly used, though usually with short-term benefits.


2020 ◽  
Vol 16 (6) ◽  
pp. 860-865
Author(s):  
Sedigheh Tavakoli-Dastjerdi ◽  
Mandana Tavakkoli-Kakhki ◽  
Ali R. Derakhshan ◽  
Azam Teimouri ◽  
Malihe Motavasselian

Background: Anal fissure (AF) is a common disease associated with severe pain and reduced quality of life. Factors related to lifestyle, including diet and bowel habits, play a pivotal role in its pathogenesis. Most of the chronic fissures are not responsive to drugs and more likely to recur. Given the significance of diet in Persian medicine (PM), investigation on physiopathology and appropriate foods can be useful for decreases in AF symptoms and consequences. Objective: This study was intended to evaluate the role of diet in the formation and progression of AF from the perspective of PM. Methods: In this study, the most important resources of PM dating back to thousands of years were reviewed. All these textbooks contained a section on AF, its causes, and treatment. Further analysis was performed on these resources in comparison with databank and resources of modern medicine to develop a food-based strategy for AF management. Results: From the view of PM, the warmth and dryness of anus temperament accounted for AF. Both Persian and modern medicine identified constipation as another cause for AF. Therefore, avoidance from some foods and commercial baked goods was recommended. Both Persian and modern medicine forbad the following foods: potato, cabbage, cauliflower, pasta, beef, fish, and so forth. High fiber and oligo-antigen diets with some limitations have garnered more attention. Conclusion: An integrative approach is recommended employing both Persian and modern medicine for AF. There have been some evidence in this regard, however standardized clinical trials are required for future research.


2020 ◽  
Vol 07 ◽  
Author(s):  
Deepika Purohit ◽  
Parijat Pandey

Background:: Cancer is one of the significant causes of morbidity and mortality in patients globally. Lung cancer, among other cancers, remains to be one of the principal causes of deaths in both men and women. The most common type of lung cancer is the non-small-cell lung cancer (NSCLC). Apart from lung cancer, pancreatic cancer is also one of the common cancers currently. Objective:: The assessment of QoL in erlotinib-treated patients can also prove to be very useful in the establishment of this drug as the main treatment option for the patients with pancreatic and lung cancer. Methods:: Therapies that target EGFR-mediated signalling are the latest keystones for treating these two types of cancers. They comprise of two main treatment modalities: firstly, against the extracellular fields, that include monoclonal antibodies and secondly, mechanisms that create interferences in the signalling pathways, primarily the small molecule tyrosine kinase inhibitors. Results:: Quality of life (QoL) is one of the key advantages in erlotinib therapy over chemotherapy. Conclusion:: The present review reports the role of erlotinib in improving the quality of life of cancer patients especially in NSCLC and pancreatic cancers. The studies or trials establishing the relations between erlotinib and QoL are discussed in detail in this review.


Author(s):  
Emily Plumadore ◽  
Lindsay Lombardo ◽  
Katherine P Cabral

Abstract Disclaimer In an effort to expedite the publication of articles , AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose This review aims to summarize the evidence and pharmacological characteristics of treatment options for transthyretin amyloid cardiomyopathy (ATTR-CM). Additionally, this review highlights the role of clinical pharmacists in helping to secure newly introduced therapies. Summary ATTR-CM, a disease characterized by misfolded protein that is deposited in the myocardium and disrupts cardiac functioning, has historically been underdiagnosed due to the need for invasive biopsy and an illusion of rarity. Once diagnosed, limited treatment modalities for ATTR-CM have led providers to rely on nonpharmacological remedies or off-label use of medications with limited evidence of benefit. However, recent noninvasive diagnostic advancements and heightened disease state awareness have revealed increased prevalence of ATTR-CM. This has led to the introduction of several first-in-class pharmaceuticals with actions targeted at inhibiting the various phases of amyloidosis: TTR stabilizers include diflunisal and first-in-class, Food and Drug Administration (FDA)-approved tafamidis; TTR silencers include patisiran and inotersen; fibril disrupters include doxycycline with tauroursodeoxycholic acid; and alternative agents include green tea extract and curcumin. Conclusion ATTR-CM treatments have emerged and, despite current limited data, are continuing to evolve. Tafamidis, the only agent approved by FDA for ATTR-CM, shows promise to improve survival and quality of life in patients with ATTR-CM. Pharmacists can play a key role in assisting with agent selection for this disease state, as well as providing knowledge about current and future clinical trials evaluating the safety and efficacy of the available treatment modalities.


Author(s):  
Virginia Sun ◽  
Tami Tittelfitz ◽  
Marjorie J. Hein

Surgery and chemotherapy are common treatment modalities used to manage disease and symptoms in palliative settings where the disease is incurable. These treatment modalities can lead to deteriorations in a patient’s quality of life (QOL). The benefits of palliative surgery and chemotherapy should always focus on QOL, symptom control, and symptom prevention. The purpose of this chapter is to provide an overview of the definition of palliative surgery and chemotherapy, describe common indications for surgery and chemotherapy for palliative treatment intent, and discuss the role of nursing in caring for patients who are receiving palliative surgery and chemotherapy.


2020 ◽  
pp. 089719002096122
Author(s):  
Hansita B. Patel ◽  
Lynsie J. Lyerly ◽  
Cheryl K. Horlen

Osteoporosis is a growing epidemic that leads to significant morbidity and mortality among the elderly population due to associated fractures that lead to disabilities and reduced quality of life. Bisphosphonates are well-established as a first-line and cost-effective treatment for osteoporosis. Unfortunately, clinicians are often uncertain as to how to select treatments when bisphosphonates are ineffective as initial treatment or contraindicated. Romosozumab and abaloparatide are 2 alternative agents that have been recently FDA approved for the treatment of osteoporosis in postmenopausal women at high risk for fracture or patients who have failed or are intolerant to other osteoporosis therapies. Currently, the National Osteoporosis Foundation (NOF) has no formal recommendations in regard to these 2 novel agents. The purpose of this review is to help guide pharmacists on how to ensure appropriate utilization of these 2 novel bone-forming agents as potential alternatives to bisphosphonate therapy by providing evidence-based recommendations according to the current literature and key counseling points.


Author(s):  
Q. Cece Chen ◽  
Shengping Zou

Postoperative pain management is an important aspect of caring for a surgical patient as inadequate pain control can be associated with increased morbidity and mortality. Failure to effectively control postoperative pain is often due to poor communication and poorly coordinated care between the care teams, poor communication with the patient, insufficient education, unrealistic expectations, fear of complications from the pain regimen, inaccurate pain assessment, and limited effective pain treatment modalities. An effective pain management can therefore lead to improved patient comfort, satisfaction, earlier ambulation, faster recovery time, decreased hospital stay and cost of care, and reduced postoperative complications.


10.2196/13170 ◽  
2020 ◽  
Vol 4 (5) ◽  
pp. e13170
Author(s):  
Alexandra Hoffmann ◽  
Corinna A Faust-Christmann ◽  
Gregor Zolynski ◽  
Gabriele Bleser

Background The use of health apps to support the treatment of chronic pain is gaining importance. Most available pain management apps are still lacking in content quality and quantity as their developers neither involve health experts to ensure target group suitability nor use gamification to engage and motivate the user. To close this gap, we aimed to develop a gamified pain management app, Pain-Mentor. Objective To determine whether medical professionals would approve of Pain-Mentor’s concept and content, this study aimed to evaluate the quality of the app’s first prototype with experts from the field of chronic pain management and to discover necessary improvements. Methods A total of 11 health professionals with a background in chronic pain treatment and 2 mobile health experts participated in this study. Each expert first received a detailed presentation of the app. Afterward, they tested Pain-Mentor and then rated its quality using the mobile application rating scale (MARS) in a semistructured interview. Results The experts found the app to be of excellent general (mean 4.54, SD 0.55) and subjective quality (mean 4.57, SD 0.43). The app-specific section was rated as good (mean 4.38, SD 0.75). Overall, the experts approved of the app’s content, namely, pain and stress management techniques, behavior change techniques, and gamification. They believed that the use of gamification in Pain-Mentor positively influences the patients’ motivation and engagement and thus has the potential to promote the learning of pain management techniques. Moreover, applying the MARS in a semistructured interview provided in-depth insight into the ratings and concrete suggestions for improvement. Conclusions The experts rated Pain-Mentor to be of excellent quality. It can be concluded that experts perceived the use of gamification in this pain management app in a positive manner. This showed that combining pain management with gamification did not negatively affect the app’s integrity. This study was therefore a promising first step in the development of Pain-Mentor.


2008 ◽  
Vol 6 (3) ◽  
pp. 0-0
Author(s):  
Eugenijus Stratilovas ◽  
Egidijus Sangaila

Eugenijus Stratilovas,  Egidijus SangailaVilniaus universiteto Onkologijos instituto Bendrosios ir abdominalinės chirurgijosir onkologijos skyrius, Santariškių g. 1, LT-08660 VilniusEl paštas: [email protected] Įvadas Viena iš dažniausiai pasitaikančių vėlyvųjų komplikacijų po stemplės rezekcinio pobūdžio operacijų yra gerybinė anastomozės striktūra. Dėl striktūros išsivysčiusi disfagija ilgam pablogina ligonio gyvenimo kokybę. Pagrindiniai šios komplikacijos gydymo metodai išlieka dažnos endoskopijos, dilatacijos bužais sukėlus nejautrą. Autoriai siūlo taikyti gana paprastą šių striktūrų gydymo metodą – dilataciją Folley kateteriu. Rezultatai Šiuo būdu gydyti keturi pacientai. Visi procedūrą pakėlė gerai, gydymo komplikacijų nebuvo. Po dviejų procedūrų rijimas tapo normalus, toliau procedūros tęstos ambulatoriškai, praėjus 3 mėn. rijimas išliko normalus. Išvada Anastomozės striktūros dilatacija Folley kateteriu yra saugus, veiksmingas ir pigus metodas. Reikšminiai žodžiai: stemplės vėžys, anastomozės striktūra, dilatacija The treatment of the benign esophagus anastomosis strictures Eugenijus Stratilovas,  Egidijus SangailaVilnius University, Institute of Oncology, Department of Generaland Abdominal Surgery and Oncology, Santariškių str. 1, LT-08660 Vilnius, LithuaniaE-mail: [email protected] Background One of the most frequent late complications after the resectable type of esophageal surgery is benign anastomosis stricture. The subsequent dysphagia worsens the patients’ quality of life for a long time. The main treatment modalities for this complication remain frequent endoscopy, dilatation using weighted bougies under anesthesia. Authors recommend use a simple mode of treatment – dilatation with the Folley catheter. Results Four patients underwent the treatment. All patients felt well, there were no treatment complications. Swallowing after two procedures became normal, the treatment was continued in outpatient clinic; after three months the swallowing was good. Conclusions Dilatation of a stricture with the Folley catheter is a safe and cost-effective method. Key words: esophageal cancer, anastomosis benign stenosis, dilatation


Sign in / Sign up

Export Citation Format

Share Document